Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 394

1.

Regenerative Capacity of Endogenous Factor: Growth Differentiation Factor 11; a New Approach of the Management of Age-Related Cardiovascular Events.

Rochette L, Meloux A, Rigal E, Zeller M, Cottin Y, Malka G, Vergely C.

Int J Mol Sci. 2018 Dec 12;19(12). pii: E3998. doi: 10.3390/ijms19123998. Review.

PMID:
30545044
2.

Sudden cardiac death: Beware of hasty diagnosis!

Guenancia C, Loffroy R, Chagué F, Cottin Y, Cochet A.

J Cardiol Cases. 2012 Dec 3;7(3):e68-e70. doi: 10.1016/j.jccase.2012.10.008. eCollection 2013 Mar.

PMID:
30533125
3.

Comparative effectiveness and safety of standard or reduced dose dabigatran versus rivaroxaban in non-valvular atrial fibrillation.

Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Clin Pharmacol Ther. 2018 Nov 30. doi: 10.1002/cpt.1318. [Epub ahead of print]

PMID:
30499605
4.

Brain-derived neurotrophic factor in peripheral blood mononuclear cells and stroke outcome.

Pedard M, Brenière C, Pernet N, Vergely C, Béjot Y, Marie C.

Exp Biol Med (Maywood). 2018 Nov 24:1535370218815612. doi: 10.1177/1535370218815612. [Epub ahead of print]

PMID:
30472884
5.

Effectiveness and safety of 110 or 150 mg dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation.

Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Br J Clin Pharmacol. 2018 Nov 13. doi: 10.1111/bcp.13815. [Epub ahead of print]

PMID:
30423205
6.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
7.

The EYE-MI Pilot Study: A Prospective Acute Coronary Syndrome Cohort Evaluated With Retinal Optical Coherence Tomography Angiography.

Arnould L, Guenancia C, Azemar A, Alan G, Pitois S, Bichat F, Zeller M, Gabrielle PH, Bron AM, Creuzot-Garcher C, Cottin Y.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4299-4306. doi: 10.1167/iovs.18-24090.

PMID:
30372758
8.

Ischemic Stroke Increases Heart Vulnerability to Ischemia-Reperfusion and Alters Myocardial Cardioprotective Pathways.

Meloux A, Rigal E, Rochette L, Cottin Y, Bejot Y, Vergely C.

Stroke. 2018 Nov;49(11):2752-2760. doi: 10.1161/STROKEAHA.118.022207.

PMID:
30355197
9.

One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.

Danchin N, Puymirat E, Cayla G, Cottin Y, Coste P, Gilard M, Goldstein P, Braun F, Belle L, Montalescot G, Ferrières J, Schiele F, Simon T; FAST-MI Investigators.

Circ Cardiovasc Interv. 2018 Sep;11(9):e007241. doi: 10.1161/CIRCINTERVENTIONS.118.007241.

PMID:
30354592
10.

Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.

Lapostolle F, Van't Hof AW, Hamm CW, Stibbe O, Ecollan P, Collet JP, Silvain J, Lassen JF, Heutz WMJM, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Ten Berg J, Zeymer U, Licour M, Tsatsaris A, Montalescot G; ATLANTIC Investigators.

Am J Cardiovasc Drugs. 2018 Oct 23. doi: 10.1007/s40256-018-0305-0. [Epub ahead of print]

PMID:
30353444
11.

Incidence, Predictive Factors, and Prognostic Impact of Silent Atrial Fibrillation After Transcatheter Aortic Valve Implantation.

Robert R, Porot G, Vernay C, Buffet P, Fichot M, Guenancia C, Pommier T, Mouhat B, Cottin Y, Lorgis L.

Am J Cardiol. 2018 Aug 1;122(3):446-454. doi: 10.1016/j.amjcard.2018.04.029. Epub 2018 May 1.

PMID:
30201110
12.

High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction.

Guenancia C, Toucas C, Fauchier L, Stamboul K, Garnier F, Mouhat B, Sagnard A, Lorgis L, Zeller M, Cottin Y.

Europace. 2018 Dec 1;20(12):e179-e188. doi: 10.1093/europace/euy168.

PMID:
30060066
13.

Validity of ambulatory blood pressure monitoring in daily primary healthcare practice in France.

Mazalovic K, Morlon F, Beis JN, Duglet PE, Cottin Y, Zabawa C.

Blood Press Monit. 2018 Dec;23(6):288-293. doi: 10.1097/MBP.0000000000000342.

PMID:
30048256
14.

Could vagal tone increase explain the excess of bradycardia episodes during the last day of the long interdialytic interval?

Pugliesi PS, Guenancia C, Cottin Y, Rebibou JM.

Kidney Int. 2018 Aug;94(2):430. doi: 10.1016/j.kint.2018.05.011. No abstract available.

PMID:
30031448
15.

Predictors of angiographically visible distal embolization in STEMI.

Yaméogo NV, Guenancia C, Porot G, Stamboul K, Richard C, Gudjoncik A, Hamblin J, Buffet P, Lorgis L, Cottin Y.

Herz. 2018 Jun 20. doi: 10.1007/s00059-018-4723-1. [Epub ahead of print]

PMID:
29926119
16.

Thirty-day rehospitalizations among elderly patients with acute myocardial infarction: Impact of postdischarge ambulatory care.

Zabawa C, Cottenet J, Zeller M, Mercier G, Rodwin VG, Cottin Y, Quantin C.

Medicine (Baltimore). 2018 Jun;97(24):e11085. doi: 10.1097/MD.0000000000011085.

17.

Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events.

Chopard R, Serzian G, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Napporn G, Kalbacher E, Obert L, Degano B, Cappelier G, Cottin Y, Schiele F, Meneveau N.

J Thromb Thrombolysis. 2018 Oct;46(3):283-291. doi: 10.1007/s11239-018-1690-6.

PMID:
29869319
18.

Short-Term Prognosis of Myocardial Injury, Type 1, and Type 2 Myocardial Infarction in the Emergency Unit.

Putot A, Derrida SB, Zeller M, Avondo A, Ray P, Manckoundia P, Cottin Y.

Am J Med. 2018 Oct;131(10):1209-1219. doi: 10.1016/j.amjmed.2018.04.032. Epub 2018 Jun 19.

PMID:
29753793
19.

Transient postnatal over nutrition induces long-term alterations in cardiac NLRP3-inflammasome pathway.

Siddeek B, Li N, Mauduit C, Chehade H, Rigal E, Tolsa JF, Armengaud JB, Yzydorczyk C, Benahmed M, Vergely C, Simeoni U.

Nutr Metab Cardiovasc Dis. 2018 Sep;28(9):944-951. doi: 10.1016/j.numecd.2018.03.013. Epub 2018 Apr 14.

PMID:
29752038
20.

Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.

Auffret V, Cottin Y, Leurent G, Gilard M, Beer JC, Zabalawi A, Chagué F, Filippi E, Brunet D, Hacot JP, Brunel P, Mejri M, Lorgis L, Rouault G, Druelles P, Cornily JC, Didier R, Bot E, Boulanger B, Coudert I, Loirat A, Bedossa M, Boulmier D, Maza M, Le Guellec M, Puri R, Zeller M, Le Breton H; ORBI and RICO Working Groups.

Eur Heart J. 2018 Jun 7;39(22):2090-2102. doi: 10.1093/eurheartj/ehy127.

PMID:
29554243

Supplemental Content

Loading ...
Support Center